Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

187 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    How the Reform of the Tax Applicable to Pharmaceutical Product Turnover Will Affect Entities in this Field

    Amendments introduced by the law of 13 August 2004 on health insurance (the "Law") with respect to the tax applied on pharmaceutical product turnover ("Pharmaceutical Tax") will affect entities carrying out a wholesale activity of pharmaceutical products (including advertising, documenting, testing and controlling as well as warehousing related to pharmaceutical products).
    FranceFood, Drugs, Healthcare, Life Sciences
    Lovells
    Lovells
  • Article

    A Look At The Impact Of The French State Of Health Emergency On Deadlines Before Administrative Courts And The Constitutional Council

    Deadlines for challenging before administrative courts: if the statutory deadline expires between March 12th and June 25th, ...
    FranceGovernment, Public Sector
Foley Hoag LLP
Foley Hoag LLP
  • Article

    The Role Clinical Trial Translation Plays In Patient Recruitment And Retention

    Health equity is an essential goal in modern healthcare, and one pivotal aspect of achieving this goal is ensuring that clinical trials are inclusive and representative of the diverse...
    GlobalFood, Drugs, Healthcare, Life Sciences
    Questel
    Questel
  • Article

    Un nouveau téléservice « Ma Certif'Pro Santé » pour contrôler l'obligation de certification périodique des professions de santé à Ordre

    Le 27 décembre 2025 a été publié au Journal Officiel le décret n° 2025-1335 [1] (« Décret ») qui vient notamment...
    FranceFood, Drugs, Healthcare, Life Sciences
    Delsol Avocats
    Delsol Avocats
  • Article

    Evolving Private Equity Strategies: A More Selective, Operational Approach To Value Creation

    At our European Health & Life Sciences Symposium 2026, conversations highlighted a market that remains active and attractive...
    FranceFood, Drugs, Healthcare, Life Sciences
    McDermott Will & Schulte
    McDermott Will & Schulte
  • Article

    The Importance Of Conscientious Health Data Collection In European Clinical Trials

    Clinical trials have become increasingly important for pharmaceutical companies and medical device manufacturers
    FranceFood, Drugs, Healthcare, Life Sciences
    Hogan Lovells
    Hogan Lovells
  • Article

    The Technology Landscape Of Precision Medicine: An IP Analysis

    IP analysis enables companies to create a technology landscape of their specific market sectors, from innovation hotspots to major industry players.
    GlobalIntellectual Property
    Questel
    Questel
  • Article

    Companies: What Is The Legal Antidote To COVID-19 In France?

    Everyone is involved in limiting the spread of this new coronavirus, and the efforts of employers must be combined with those of employees.
    FranceEmployment and HR
    Hogan Lovells
    Hogan Lovells
  • Article

    Médecins En Secteur 3 : Déremboursement Des Prescriptions

    A new French law threatens to eliminate reimbursement for prescriptions written by non-conventioned physicians, forcing doctors in "secteur 3" to reconsider their status. The Conseil d'État has refused to block this measure, which will fundamentally alter the relationship between these practitioners and their patients starting January 1, 2027.
    FranceFood, Drugs, Healthcare, Life Sciences
    Delsol Avocats
    Delsol Avocats
  • Article

    The Worst E-Commerce Sites For Counterfeit Products Online

    The '2024 Review of Notorious Markets for Counterfeiting and Piracy' by the US Trade Representative (USTR) reveals some positive developments in anti-counterfeiting by e-marketplaces...
    European UnionIntellectual Property
    Novagraaf Netherlands BV
    Novagraaf Netherlands BV
  • Article

    Covid-19 And Contact Tracing

    While France is entering the first phase of its end-of-lockdown plan, the Government's strategy to combat a resumption of the epidemic is now based on monitoring "contact tracing".
    FranceCoronavirus (COVID-19)
    Soulier Avocats
    Soulier Avocats
  • Article

    Hazardous Mixtures And Health Emergency, Are You Ready For The January 1, 2021 Deadline?

    Companies placing hazardous mixtures on the market have to submit information about these mixtures to specific bodies appointed by European Union Member States.
    FranceFood, Drugs, Healthcare, Life Sciences
    Soulier Avocats
    Soulier Avocats
  • Article

    Mélanges Dangereux Et Urgence Sanitaire, Prêts Pour L'échéance Du Premier Janvier 2021 ?

    Les entreprises qui mettent sur le marché des mélanges dangereux doivent soumettre des informations sur ces mélanges à des organismes spécifiques désignés par les États membres de l'Union européenne.
    FranceFood, Drugs, Healthcare, Life Sciences
    Soulier Avocats
    Soulier Avocats
  • Article

    IA En Santé : Quelles Sont Les Précautions À Prendre ?

    A ce titre, les algorithmes d'IA permettent à partir d'une masse de données d'aider à reconnaitre, pronostiquer et diagnostiquer une maladie.
    FranceTechnology
    Haas Avocats
    Haas Avocats
  • Article

    Covid-19 : Publication De La Lettre De Confort De La Commission Européenne Qui Permet Une Coopération Entre Producteurs Pharmaceutiques Pour Lutter Contre La Pénurie De Médicaments

    Renaud Christol Marc-Antoine Picquier
    FranceCoronavirus (COVID-19)
    August Debouzy
    August Debouzy
  • Article

    La Collecte Des Données Personnelles Par Les Applis De Suivi Menstruel

    Alors que de nombreux Etats américains interdisent désormais l'avortement ou sont en voie de le faire, des interrogations émergent quant aux éventuelles poursuites qui seront intentées...
    FrancePrivacy
    Haas Avocats
    Haas Avocats
  • Article

    Likelihood Of Confusion Is Based On The Relevant Public's Understanding, Rules EU General Court

    In Pharmadom v European Union Intellectual Property Office (EUIPO), the General Court discussed the assessment of the likelihood of confusion in the light of the understanding...
    European UnionIntellectual Property
    Novagraaf Netherlands BV
    Novagraaf Netherlands BV
  • Article

    French Competition Authority—for The First Time—sanctions Below-threshold Deal Under Abuse Of Dominance Provisions

    The French Competition Authority (FCA) has fined Doctolib a total of EUR4.7 million for abusing its dominant position in the markets for online medical appointment booking services...
    FranceAntitrust/Competition Law
    A&O Shearman
    A&O Shearman
  • Article

    Governmental Measures Amending Certain Time Limits In The Context Of The Covid-19 Health Crisis

    The confinement and social distancing measures imposed by the government to combat the spread of covid-19 are not without effect on the French judicial system.
    FranceCoronavirus (COVID-19)
    August Debouzy
    August Debouzy
  • Article

    Hébergement de données de santé : que faut-il retenir du nouveau référentiel HDS ?

    La réforme du référentiel de certification des hébergeurs de données de santé (HDS) datant de 2018, était annoncée de longue date, pour tenir compte...
    FranceFood, Drugs, Healthcare, Life Sciences
    Haas Avocats
    Haas Avocats
  • Showing 101–120 of 187 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics